News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,163 Results
Type
Article (39079)
Company Profile (281)
Press Release (646803)
Section
Business (204011)
Career Advice (1991)
Deals (35384)
Drug Delivery (85)
Drug Development (80804)
Employer Resources (168)
FDA (16092)
Job Trends (14806)
News (344723)
Policy (32447)
Tag
Academia (2532)
Alliances (49156)
Alzheimer's disease (1229)
Approvals (16024)
Artificial intelligence (130)
Bankruptcy (353)
Best Places to Work (11538)
Biotechnology (200)
Breast cancer (120)
Cancer (1087)
Cardiovascular disease (97)
Career advice (1660)
Cell therapy (234)
Clinical research (64255)
Collaboration (388)
Compensation (200)
COVID-19 (2530)
C-suite (94)
Data (1126)
Diabetes (152)
Diagnostics (6143)
Earnings (84836)
Employer resources (146)
Events (109550)
Executive appointments (310)
FDA (16631)
Funding (353)
Gene therapy (178)
GLP-1 (577)
Government (4327)
Healthcare (18670)
Infectious disease (2615)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16304)
Job creations (3625)
Job search strategy (1417)
Layoffs (412)
Legal (7856)
Lung cancer (170)
Manufacturing (177)
Medical device (13177)
Medtech (13182)
Mergers & acquisitions (19160)
Metabolic disorders (402)
Neuroscience (1504)
NextGen Class of 2024 (6502)
Non-profit (4464)
Northern California (1481)
Obesity (232)
Opinion (179)
Patents (102)
People (56323)
Phase I (19957)
Phase II (28304)
Phase III (21099)
Pipeline (458)
Postmarket research (2554)
Preclinical (8495)
Radiopharmaceuticals (236)
Rare diseases (219)
Real estate (5895)
Regulatory (21531)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1302)
Startups (3567)
United States (13502)
Vaccines (549)
Weight loss (168)
Date
Today (1)
Last 7 days (667)
Last 30 days (3577)
Last 365 days (35661)
2024 (32756)
2023 (40082)
2022 (51179)
2021 (55723)
2020 (54097)
2019 (46556)
2018 (35023)
2017 (32125)
2016 (31494)
2015 (37577)
2014 (31350)
2013 (26376)
2012 (28602)
2011 (29291)
2010 (27360)
Location
Africa (713)
Arizona (192)
Asia (37142)
Australia (6063)
California (3332)
Canada (1295)
China (252)
Colorado (147)
Connecticut (153)
Europe (79630)
Florida (461)
Georgia (116)
Illinois (341)
Indiana (196)
Kansas (96)
Maryland (575)
Massachusetts (2612)
Michigan (158)
Minnesota (273)
New Jersey (957)
New York (964)
North Carolina (702)
Northern California (1481)
Ohio (139)
Pennsylvania (847)
South America (1093)
Southern California (1302)
Texas (465)
Utah (90)
Washington State (362)
686,163 Results for "leica biosystems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Leica Biosystems Receives FDA 510(k) Clearance for Aperio GT 450 DX Digital Pathology System with both SVS and Native DICOM
Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has received 510(k) clearance from the US Food and Drug Administration.
April 29, 2024
·
2 min read
Press Releases
Leica Microsystems introduces a new online shopping experience
September 16, 2024
·
2 min read
Leica Biosystems Strengthens Portfolio with FDA Clearance of Class II Mismatch Repair (MMR) Panel
Leica Biosystems today announced the US Food and Drug Administration (FDA) 510(k) clearance of the BOND MMR Antibody Panel, providing customers with a high-performing IHC Mismatch Repair (MMR) option when screening colorectal cancer patients for the identification of probable Lynch syndrome.
April 3, 2023
·
2 min read
Genetown
T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, announced the execution of a territory exclusive distribution agreement in Hong Kong and Macau.
June 25, 2024
·
4 min read
Deals
Leica Biosystems Acquires Cell IDx, Moving its Multiplexing Menu Forward with Ready-to-Use, Pre-Kitted Formulations
Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging, has acquired Cell IDx, Inc., a leader in multiplexed tissue profiling.
November 8, 2022
·
3 min read
Genetown
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced the conversion of an additional $15 million of its term loan with entities affiliated with CRG Servicing LLC into T2 Biosystems equity.
May 6, 2024
·
4 min read
Genetown
T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, announced the execution of a territory exclusive distribution agreement in Qatar.
May 6, 2024
·
5 min read
Business
Leica Biosystems Announces Partnership with Indica Labs to Deliver Integrated Digital Pathology Workflow Solutions for Mutual Customers
Leica Biosystems announced a partnership focused on delivering compatible digital pathology workflow solutions.
September 6, 2022
·
2 min read
Press Releases
T2 Biosystems Announces Third Quarter 2024 Financial Results
November 15, 2024
·
10 min read
Business
T2 Biosystems Announces First Quarter 2024 Financial Results
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced unaudited financial and operational results for the first quarter ended March 31, 2024.
May 6, 2024
·
10 min read
1 of 68,617
Next
